Like most new services, having the option to “try something small before fully committing” is key. Teams want to run a quick pilot to evaluate the process, data quality, and value of high-parameter cytometry before jumping into larger clinical programs. It’s a smart way to de-risk. But even then, planning the pilot can be the thing that slows everything down.
TokuPilot removes that friction. It’s a ready-to-run, pre-defined pilot that simplifies planning and speeds up onboarding. Teams can skip the back-and-forth, say yes to a few clear options, and get to “Let’s do that” in no time. That means less time on logistics, and more time focused on what matters: what samples to run, what comparisons to make, and getting high-quality, low-CV data in hand, fast.
Each TokuPilot includes either 10 or 20 PBMC or TokuKit-fixed whole blood samples, with options to use Teiko’s 41-marker mass cytometry panel for PBMC or whole blood, or the 25-marker spectral cytometry panel for PBMC or whole blood. Both panels are CLIA-validated with intra- and inter-run precision testing. Choose between two analysis tiers: Core or Premier, the latter including unsupervised clustering analysis (UMAP!). Projects completed in 3 weeks from sample receipt, with results delivered through your own Online TokuProfile Dashboard.
Candidly, we live in this economy, and know teams are thinking more critically about their budgets. That’s why we’re offering up to 40% off TokuPilot, with projects starting at ~$12K.
Why the low price? Because we’re confident that once you work with Teiko, you’ll be back. Over 90 percent of our customers go on to launch larger follow-up projects, so we've got track record to back it up.
TokuPilot projects are designed to help teams test out the types of comparisons they would explore at scale in a clinical trial, specifically using high-dimensional cytometry. Many teams use pilots to compare responders versus non-responders, disease versus healthy samples at baseline, or different dosing groups. Some use it to explore differences across timepoints, like pre and post treatment. These designs help uncover immune signatures relevant to safety or efficacy, before scaling to larger studies.
“We heard from our customers that the hardest part wasn’t saying yes to a pilot. It was figuring out how to start one,” said Justin Jarrell, Chief Commercial Officer at Teiko. “With TokuPilot, they can get started in days, see results in a couple of weeks, and quickly understand the value of high-parameter cytometry in their own data. It’s powerful.”
TokuPilot removes the big-thinking barriers that slow teams down. Instead of staying in planning paralysis, TokuPilot makes it easy to make decisions and move quickly to getting samples in our hands, and results in yours.
With TokuPilot, teams can:
Let’s make it happen, and get you on high-dimensions. Message us here to get started.
For pricing, quotes, or more information, visit www.teiko.bio or message us at teiko.bio/contact.
.png)
